Evolus (EOLS) Amortization of Deferred Charges (2018 - 2026)
Evolus' (EOLS) quarterly Amortization of Deferred Charges came in at $361000.0 in Q1 2026, up 37.26% YoY from $263000.0 in Q1 2025, and up 7.76% on a QoQ basis from $335000.0 in Q4 2025.
Evolus (EOLS) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends
Evolus (EOLS) has 9 years of Amortization of Deferred Charges data on file, last reported at $361000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 37.26% year-over-year to $361000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 5.78% YoY) and the FY2025 annual result came in at $1.2 million, up 7.85% from the prior year.
- Amortization of Deferred Charges improved to $361000.0 in Q1 2026, from $335000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $662000.0 in Q4 2024 to a low of $13000.0 in Q3 2023.
- A 5-year average of $250235.3 and a median of $263000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges sank 86.75% — and 2024, when it soared 1315.38%.
- Tracing EOLS's Amortization of Deferred Charges over 5 years: stood at $202000.0 in 2022, then declined by 28.71% to $144000.0 in 2023, then surged by 359.72% to $662000.0 in 2024, then tumbled by 49.4% to $335000.0 in 2025, then rose by 7.76% to $361000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $361000.0 (Q1 2026), $335000.0 (Q4 2025), and $292000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 404,000.00 |
| Jun 30, 2026 | 404,000.00 |
| Mar 31, 2026 | 361,000.00 |
| Mar 31, 2026 | 361,000.00 |
| Dec 31, 2025 | 335,000.00 |
| Dec 31, 2025 | 335,000.00 |
| Sep 30, 2025 | 292,000.00 |
| Sep 30, 2025 | 292,000.00 |
| Jun 30, 2025 | 347,000.00 |
| Jun 30, 2025 | 347,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Mar 31, 2024 | 148,000.00 |